Risk factors for clinically diagnosed uterine fibroids in women around menopause

Maturitas

Volumn 55, Issue 2, 2006, Pages 174-179

  Parazzini, Fabio ^a  

^a AOGOI   (Italy)

Author keywords

Fibroids; Menopause; Risk factors

Indexed keywords

ADULT; ARTICLE; BIRTH; BODY MASS; CONFIDENCE INTERVAL; COUNSELING; FEMALE; GESTATIONAL AGE; GYNECOLOGICAL EXAMINATION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE ANALYSIS; MYOMECTOMY; NULLIPARA; OBESITY; OUTPATIENT; PARITY; RISK ASSESSMENT; RISK FACTOR; ULTRASOUND; UTERUS MYOMA;

AGE FACTORS; BODY MASS INDEX; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; LEIOMYOMA; LIFE STYLE; MENOPAUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; UTERINE NEOPLASMS;

EID: 33748100220     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.01.013     Document Type: Article

References (33)

1. Vollenhoven B. Introduction: the epidemiology of uterine leiomyomas. Baillieres Clin Obstet Gynaecol 12 (1998) 169
2. Marshall L.M., Spiegelman D., Goldman M.B., et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70 (1998) 432-439
3. Faerstein E., Szklo M., and Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 153 (2001) 1-10
4. Marshall L.M., Spiegelman D., Manson J.E., et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 9 (1998) 511-517
5. Schwartz S.M. Invited commentary: studying the epidemiology of uterine leiomyomata-past, present, and future. Am J Epidemiol 153 (2001) 27-29
6. Baird D.D., Dunson D.B., Hill M.C., Cousins D., and Schectman J.M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188 (2003) 100-107
7. Chen C.R., Buck G.M., Courey N.G., Perez K.M., and Wactawski-Wende J. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol 153 (2001) 20-26
8. Parazzini F., La Vecchia C., Negri E., Cecchetti G., and Fedele L. Epidemiologic characteristics of women with uterine fibroids: a case-control study. Obstet Gynecol 72 (1988) 853-857
9. Ross R.K., Pike M.C., Vessey M.P., Bull D., Yeates D., and Casagrande J.T. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 293 (1986) 359-362
10. Parazzini F., Negri E., La Vecchia C., Chatenoud L., Ricci E., and Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology 7 (1996) 440-442
11. Wise L.A., Palmer J.R., Harlow B., et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 159 (2004) 113-123
12. Chiaffarino F., Parazzini F., La Vecchia C., Marsico S., Surace M., and Ricci E. Use of oral contraceptives and uterine fibroids: results from a case-control study. Br J Obstet Gynaecol 106 (1999) 857-860
13. Chiaffarino F., Parazzini F., La Vecchia C., Ricci E., and Crosignani P.G. Oral contraceptive use and benign gynecologic conditions. Contraception 57 (1998) 11-18
14. Royal College of General Practitioners. Oral contraceptives and health. An interim report from the oral contraceptive study of the Royal College of General Practitioners. London: Pitman Medical Publishing; 1974.
15. Parazzini F., Negri E., La Vecchia C., Fedele L., Rabaiotti M., and Luchini L. Oral contraceptive use and risk of uterine fibroids. Obstet Gynecol 79 (1992) 430-433
16. Wise L.A., Palmer J.R., Spiegelman D., et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 16 (2005) 346-354
17. Lumbiganon P., Rugpao S., Phandhu-fung S., Laopaiboon M., Vudhikamraksa N., and Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: A multicentre case-control study. Br J Obstet Gynaecol 103 (1996) 909-914
18. Romieu I., Walker A.M., and Jick S. Determinants of uterine fibroids. Post Marketing Surveillance 5 (1991) 119-133
19. Faerstein E., Szklo M., and Rosenshein N.B. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 153 (2001) 11-19
20. Summers W.E., Watson R.L., Wooldridge W.H., and Langford H.G. Hypertension, obesity, and fibromyomata uteri, as a syndrome. Arch Intern Med 128 (1971) 750-754
21. Parazzini F., Chiaffarino F., Polverino G., Chiantera V., Surace M., and La Vecchia C. Uterine fibroids risk and history of selected medical conditions linked with female hormones. Eur J Epidemiol 19 (2004) 249-253
22. Marshall L.M., Spiegelman D., Barbieri R.L., et al. Variation in the incidence of uterine leiomyoma in black and white women by age and race. Obetet Gynecol 90 (1997) 967-973
23. Pasetto N, Giacomello F, Patologia benigna dell'utero. La clinica Ostetrica e Ginecologica Candiani GB. In: Danesino V, Gastaldi A, eds. Masson; 1996, p. 1521.
24. Progetto Menopausa Italia Study Group. Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy. Maturitas 36 (2000) 19-25
25. Progetto Menopausa Italia Study Group. Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. Br J Obstet Gynaecol 110 (2003) 59-63
26. Baker R.J., and Nelder J.A. The GLIM system. Release 3 (1978), Numerical Algorithms Group, Oxford
27. La Vecchia C., Decarli A., Negri E., Ferraroni M., and Pagano R. Height and the prevalence of chronic disease. Rev Epidemiol Sante Publ 40 (1992) 6-14
28. Ang W.C., Farrell E., and Vollenhoven B. Effect of hormone replacement therapies and selective estrogen receptor modulators in post-menopausal women with uterine leiomyomas: a literature review. Climacteric 4 (2001) 284-292
29. Colacurci N., De Franciscis P., Mele D., Palermo M., and Del Vecchio W. Effects of hormone replacement therapy on post-menopausal uterine myoma. Maturitas 29 (2000) 167-173
30. Sener A.B., Seckin N.C., Ozmen S., Gokmen O., Dogu N., and Ekici E. The effects of hormone replacement therapy on uterine fibroids in post-menopausal women. Fertil Steril 65 (1996) 354-357
31. Fedele L., Parazzini F., Luchini L., Mezzopane R., Tozzi L., and Villa L. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod 10 (1995) 1795-1796
32. Parazzini F., La Vecchia C., Franceschi S., Negri E., and Cecchetti G. Risk factors for endometrioid, mucinous and serous benign ovarian cysts. Int J Epidemiol 18 (1989) 108-112
33. Gruppo Italiano Studi Endometriosi, and Parazzini F. Risk factors for pelvic endometriosis in women with pelvic pain or infertility. Eur J Obstet Gynecol Reprod Biol 83 (1999) 195-199